Page last updated: 2024-10-21

meglutol and Cholelithiasis

meglutol has been researched along with Cholelithiasis in 1 studies

Meglutol: An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.
3-hydroxy-3-methylglutaric acid : A dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura.

Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Padova, C1
Di Padova, F1
Buzzetti, M1
Tritapepe, R1

Trials

1 trial available for meglutol and Cholelithiasis

ArticleYear
Effect of 3-hydroxy-3-methylglutaric acid administration on bile lipid composition in humans.
    Scandinavian journal of gastroenterology, 1984, Volume: 19, Issue:6

    Topics: Adult; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Clinical Trials as Topic; Double-Bli

1984